Cover ImageSALE
市場調查報告書

核子醫學攝影的全球市場:2017年∼2021年

Global Nuclear Imaging Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325829
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
核子醫學攝影的全球市場:2017年∼2021年 Global Nuclear Imaging Market 2017-2021
出版日期: 2017年08月09日 內容資訊: 英文 117 Pages
簡介

核子醫學攝影的全球市場,預計從2017年到2021年期間,以6.01%的年複合成長率成長。

本報告提供核子醫學攝影的全球市場的現狀與成長預測,市場規模和與今後的成長預測,市場成長因素與課題,主要供應商分析等,為您概述為以下內容。

第1章 摘要整理

第2章 調查範圍

第3章 市場調查手法

第4章 簡介

  • 市場概要

第5章 市場形勢

  • 市場概要
  • 波特的五力分析

第6章 市場區隔:各應用領域

  • 腫瘤學
  • 心臟學
  • 神經學
  • 其他

第7章 市場區隔:各產品

  • 獨立式PET核子醫學攝影市場
  • 獨立式SPECT核子醫學攝影市場
  • 混合型核子醫學攝影市場

第8章 市場區隔:各終端用戶

  • 醫院
  • 診斷中心
  • 研究中心

第9章 各地理區分

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 決策結構

第11章 市場成長的推動要素與課題

第12章 市場趨勢

第13章業者情勢

  • 競爭模式
  • 主要消息

第14章 主要供應商分析

  • Digirad
  • GE Healthcare
  • Mediso
  • Koninklijke Philips
  • Siemens Healthcare
  • 其他有潛力的供應商

第15章 附錄

  • 簡稱清單

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR14313

About Nuclear Imaging

Nuclear imaging is a branch of medical imaging which uses small amounts of radioactive tracers to diagnose, to determine severity of the disease, and treat various chronic disorders such as cancers, cardiac diseases, gastrointestinal and neurological abnormalities. PET nuclear imaging has multiple applications in clinical neurology, includes epilepsy, movement disorders, brain tumors, dementia, neuronal plasticity, and stroke. Also, it is used to diagnose oncology, cardiology (has some limited applications), and other neurodegenerative disorders. However, the majority of PET scans are used to diagnose and treat cancers. The radioactive tracers concentrate in the regions of cancer, which are detected by the PET nuclear imaging.

Technavio's analysts forecast the global nuclear imaging market to grow at a CAGR of 6.01% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global nuclear imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated form the new nuclear imaging equipment sales.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Nuclear Imaging Market 2017-2021 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GE Healthcare,
  • Siemens Healthcare,
  • Koninklijke Philips,
  • Digirad
  • Mediso Medical Imaging Systems

Other Prominent Vendors

  • Advanced Accelerator Applications
  • Agfa-Gevaert
  • BC Technical
  • CardiArc
  • Cardinal Health
  • Carestream Health
  • CMR Naviscan
  • Cubresa
  • DDD-Diagnostic
  • Eczacibasi-Monrol Nuclear Products
  • FMI Medical Systems
  • FUJIFILM Holdings
  • MiE America
  • MILabs
  • NeuroLogica
  • Neusoft Medical Systems
  • Photo Diagnostic Systems
  • RadioMedix
  • Sofie Biosciences
  • Spectrum Dynamics Medical
  • SynchroPET
  • Toshiba Medical Systems

Market driver

  • Increasing prevalence of chronic diseases
  • For a full, detailed list, view our report

Market challenge

  • Risks and safety issues associated with nuclear imaging and radiation exposure
  • For a full, detailed list, view our report

Market trend

  • Growing focus on developing PET/MRI hybrid imaging systems
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by application

  • Oncology
  • Cardiology
  • Neurology
  • Others

PART 07: Market segmentation by product

  • Standalone PET nuclear imaging
  • Standalone SPECT nuclear imaging
  • Hybrid nuclear imaging

PART 08: Market segmentation by end-user

  • Hospitals
  • Diagnostic centers
  • Research centers

PART 09: Geographical segmentation

  • Nuclear imaging market in Americas
  • Nuclear imaging market in EMEA
  • Nuclear imaging market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Emergence of time of flight (TOF) nuclear imaging systems
  • Growing focus on developing PET/MRI hybrid imaging systems
  • Vendors' focus on emerging economies
  • Growing focus on cyclotron-based production
  • Advances in radionanomedicine

PART 13: Vendor landscape

  • Competitive scenario
  • Key news

PART 14: Key vendor analysis

  • Digirad
  • GE Healthcare
  • Mediso
  • Koninklijke Philips
  • Siemens Healthcare
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global nuclear imaging market by application 2016 (%)
  • Exhibit 04: Global nuclear imaging market by product 2016 ($ millions)
  • Exhibit 05: Global nuclear imaging market by product 2016-2021 ($ millions)
  • Exhibit 06: Global nuclear imaging market by product 2016-2021 (%)
  • Exhibit 07: Global nuclear imaging market by product 2016 and 2021 (%)
  • Exhibit 08: Global nuclear imaging market by product 2016 and 2021 ($ millions)
  • Exhibit 09: Global nuclear imaging market by product 2016 (%)
  • Exhibit 10: Nuclear imaging market by product type 2016
  • Exhibit 11: Snapshot of global PET nuclear imaging market 2016
  • Exhibit 12: Global standalone PET nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 13: Snapshot of global SPECT nuclear imaging market 2016
  • Exhibit 14: Global standalone SPECT nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 15: Snapshot of global hybrid nuclear imaging market 2016
  • Exhibit 16: Global hybrid nuclear imaging market 2016-2021 ($ millions)
  • Exhibit 17: Global nuclear imaging market by end-users 2016 (%)
  • Exhibit 18: Global nuclear imaging market by geography 2016
  • Exhibit 19: Global nuclear imaging market by geography 2016-2021 ($ millions)
  • Exhibit 20: Global nuclear imaging market by geography 2016-2021 (%)
  • Exhibit 21: Global nuclear imaging market by geography 2016 and 2021 ($ millions)
  • Exhibit 22: Global nuclear imaging market by geography 2016 and 2021 (%)
  • Exhibit 23: Nuclear imaging market in Americas 2016-2021 ($ millions)
  • Exhibit 24: Nuclear imaging market in EMEA 2016-2021 ($ millions)
  • Exhibit 25: Nuclear imaging market in APAC 2016-2021 ($ millions)
  • Exhibit 26: Advantages of cyclotron-based radioisotopes production
  • Exhibit 27: Competitive structure analysis of global nuclear imaging market 2016
  • Exhibit 28: Digirad: Key highlights
  • Exhibit 29: Digirad: Strength assessment
  • Exhibit 30: Digirad: Strategy assessment
  • Exhibit 31: Digirad: Opportunity assessment
  • Exhibit 32: GE Healthcare: Key highlights
  • Exhibit 33: GE Healthcare strength assessment
  • Exhibit 34: GE Healthcare strategy assessment
  • Exhibit 35: GE Healthcare opportunity assessment
  • Exhibit 36: Mediso: Key highlights
  • Exhibit 37: Mediso: Strength assessment
  • Exhibit 38: Mediso: Strategy assessment
  • Exhibit 39: Mediso: Opportunity assessment
  • Exhibit 40: Koninklijke Philips: Key highlights
  • Exhibit 41: Koninklijke Philips: Strength assessment
  • Exhibit 42: Koninklijke Philips: Strategy assessment
  • Exhibit 43: Koninklijke Philips: Opportunity assessment
  • Exhibit 44: Siemens Healthcare: Key highlights
  • Exhibit 45: Siemens Healthcare: Strength assessment
  • Exhibit 46: Siemens Healthcare: Strategy assessment
  • Exhibit 47: Siemens Healthcare: Opportunity assessment
Back to Top